3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Carcinoma, Non-Small-Cell Lung
23
Lung Neoplasms
12
Prostatic Neoplasms
10
Squamous Cell Carcinoma of Head and Neck
8
Breast Neoplasms
5
Stomach Neoplasms
4
Prostatic Neoplasms, Castration-Resistant
4
Neoplasms
4
Neoplasm Metastasis
3
Endometrial Neoplasms
3
Carcinoma, Transitional Cell
3
Carcinoma
3
Urinary Bladder Neoplasms
2
Triple Negative Breast Neoplasms
2
Parkinson Disease 4, Autosomal Dominant Lewy Body
2
Oropharyngeal Neoplasms
2
Nasopharyngeal Carcinoma
2
Melanoma
2
Lymphoid Interstitial Pneumonia
2
Head and Neck Neoplasms
2
HER2-positive Breast Cancer
2
Esophageal Neoplasms
2
Anatomic Stage I Breast Cancer AJCC v8
2
Vaccinia
1
Uterine Neoplasms
1
Uterine Cervical Neoplasms
1
Urothelial Cancer
1
Tongue Neoplasms
1
Stage I Prostate Adenocarcinoma AJCC v7
1
Solid Tumors
1
Interventions
pembrolizumab
2
tremelimumab
1
poly ICLC
1
lenvatinib
1
durvalumab
1
balstilimab
1
Peptides
1
Pemetrexed
1
Carboplatin
1
Blood Specimen Collection
1
130-nm albumin-bound paclitaxel
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Diabetes Mellitus, Insulin-Dependent, 12
×
Docetaxel
×
30 days
×
Clear all
No trials found.